Arcadia Biosciences Inc (NASDAQ:RKDA) price on Thursday, July 03, rose 0.43% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $4.65.
A look at the stock’s price movement, the close in the last trading session was $4.63, moving within a range at $4.46 and $5.19. The beta value (5-Year monthly) was 0.518. Turning to its 52-week performance, $10.31 and $2.40 were the 52-week high and 52-week low respectively. Overall, RKDA moved 0.87% over the past month.
Arcadia Biosciences Inc’s market cap currently stands at around $6.36 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-08.
Turning to the stock’s technical picture we see that short term indicators suggest on average that RKDA is a 50% Buy. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend RKDA as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
RKDA’s current price about -0.43% and 8.24% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 55.12, while 7-day volatility ratio is 9.77% and 7.43% in the 30-day chart. Further, Arcadia Biosciences Inc (RKDA) has a beta value of 0.50. Analysts have given the company’s stock an average 52-week price target of $6, forecast between a low of $6 and high of $6. Looking at the price targets, the low is -29.03% off current price level while to achieve the yearly target high, price needs to move -29.03%. Nonetheless, investors will most likely welcome a -29.03% jump to $6 which is the analysts’ median price.
If we refocus on Arcadia Biosciences Inc (NASDAQ:RKDA), historical trading data shows that trading volumes averaged 30100.0 over the past 10 days and 15.19K over the past 3 months. The company’s latest data on shares outstanding shows there are 1.37 million shares.
The 0.82% of Arcadia Biosciences Inc’s shares are in the hands of company insiders while institutional holders own 5.60% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 22249.0 on 2025-06-13, giving us a short ratio of 1.72. The data shows that as of 2025-06-13 short interest in Arcadia Biosciences Inc (RKDA) stood at 164.0 of shares outstanding, with shares short rising to 19344.0 registered in 2025-05-15. Current price change has pushed the stock 47.62% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the RKDA stock continues to rise going into the next quarter.
